Ayan, A. K. Et Al. 2016. Is there any correlation between levels of serum ostepontin, CEA, and FDG uptake in lung cancer patients with bone metastasis?. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR , vol.35, no.2 , 102-106.

Ayan, A. K., ERDEMCİ, B., Orsal, E., Bayraktutan, Z., AKPINAR, E., Topcu, A., ... Turkeli, M.(2016). Is there any correlation between levels of serum ostepontin, CEA, and FDG uptake in lung cancer patients with bone metastasis?. REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR , vol.35, no.2, 102-106.

Ayan, A. Et Al. "Is there any correlation between levels of serum ostepontin, CEA, and FDG uptake in lung cancer patients with bone metastasis?," REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR , vol.35, no.2, 102-106, 2016

Ayan, A. K. Et Al. "Is there any correlation between levels of serum ostepontin, CEA, and FDG uptake in lung cancer patients with bone metastasis?." REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR , vol.35, no.2, pp.102-106, 2016

Ayan, A. K. Et Al. (2016) . "Is there any correlation between levels of serum ostepontin, CEA, and FDG uptake in lung cancer patients with bone metastasis?." REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR , vol.35, no.2, pp.102-106.

@article{article, author={A. K. Ayan Et Al. }, title={Is there any correlation between levels of serum ostepontin, CEA, and FDG uptake in lung cancer patients with bone metastasis?}, journal={REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR}, year=2016, pages={102-106} }